Skip to content

Nitric oxide

Genosyl, Inomax, INOmax (nitric oxide) is a small molecule pharmaceutical. Nitric oxide was first approved as Genosyl on 1999-12-23. It is used to treat newborn respiratory distress syndrome in the USA. It has been approved in Europe to treat pulmonary hypertension and respiratory insufficiency. It is known to target potassium channel subfamily K member 17 and potassium channel subfamily K member 16. Inomax's patents are valid until 2036-05-03 (FDA).
Trade Name INOmax
Common Name Nitric oxide
Indication newborn respiratory distress syndrome, pulmonary hypertension, respiratory insufficiency
Drug Class
Nitric oxide
Get full access now